Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Critics Say Controversy About Diabetes Drug Points To Need For Agency Changes
FDA examines the safety of Glaxo's Avandia pill.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
